New targets for therapy: antigen identification in adults with B-cell acute lymphoblastic leukaemia
- Standort
-
Deutsche Nationalbibliothek Frankfurt am Main
- ISSN
-
1432-0851
- Umfang
-
Online-Ressource
- Sprache
-
Englisch
- Anmerkungen
-
online resource.
- Erschienen in
-
New targets for therapy: antigen identification in adults with B-cell acute lymphoblastic leukaemia ; day:22 ; month:1 ; year:2020 ; pages:1-11
Cancer immunology immunotherapy ; (22.1.2020), 1-11
- Urheber
-
Jordaens, Stephanie
Cooksey, Leah
Freire Boullosa, Laurie
Van Tendeloo, Viggo
Smits, Evelien
Mills, Ken I.
Orchard, Kim H.
Guinn, Barbara
- Beteiligte Personen und Organisationen
-
SpringerLink (Online service)
- DOI
-
10.1007/s00262-020-02484-0
- URN
-
urn:nbn:de:101:1-2020042401012358391653
- Rechteinformation
-
Open Access; Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Letzte Aktualisierung
-
14.08.2025, 10:53 MESZ
Datenpartner
Dieses Objekt wird bereitgestellt von:
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Beteiligte
- Jordaens, Stephanie
- Cooksey, Leah
- Freire Boullosa, Laurie
- Van Tendeloo, Viggo
- Smits, Evelien
- Mills, Ken I.
- Orchard, Kim H.
- Guinn, Barbara
- SpringerLink (Online service)
Ähnliche Objekte (12)
NG2 antigen is a therapeutic target for MLL-rearranged B-cell acute lymphoblastic leukemia
Whole genome sequencing provides comprehensive genetic testing in childhood B-cell acute lymphoblastic leukaemia
VEGF - a novel therapeutic target in central nervous system acute lymphoblastic leukaemia
Uncommon manifestations of acute lymphoblastic leukaemia (ALL)
The age of the bone marrow microenvironment influences B-cell acute lymphoblastic leukaemia progression via CXCR5-CXCL13
Emerging molecular subtypes and therapeutic targets in B-cell precursor acute lymphoblastic leukemia
Characterisation of FLT3 alterations in childhood acute lymphoblastic leukaemia
Correction to: Pegaspargase: A Review in Acute Lymphoblastic Leukaemia
Molecular processes involved in B cell acute lymphoblastic leukaemia
TARGET based m6A methylation-related genes predict prognosis relapsed B-cell acute lymphoblastic leukemia
Temporal changes of the incidence of childhood B-cell precursor acute lymphoblastic leukaemia in Germany during the COVID-19 pandemic
Chromosomal instability in the development of childhood acute lymphoblastic leukaemia
NG2 antigen is a therapeutic target for MLL-rearranged B-cell acute lymphoblastic leukemia
Whole genome sequencing provides comprehensive genetic testing in childhood B-cell acute lymphoblastic leukaemia
VEGF - a novel therapeutic target in central nervous system acute lymphoblastic leukaemia
Uncommon manifestations of acute lymphoblastic leukaemia (ALL)
The age of the bone marrow microenvironment influences B-cell acute lymphoblastic leukaemia progression via CXCR5-CXCL13
Emerging molecular subtypes and therapeutic targets in B-cell precursor acute lymphoblastic leukemia
Characterisation of FLT3 alterations in childhood acute lymphoblastic leukaemia
Correction to: Pegaspargase: A Review in Acute Lymphoblastic Leukaemia
Molecular processes involved in B cell acute lymphoblastic leukaemia
TARGET based m6A methylation-related genes predict prognosis relapsed B-cell acute lymphoblastic leukemia
Temporal changes of the incidence of childhood B-cell precursor acute lymphoblastic leukaemia in Germany during the COVID-19 pandemic
Chromosomal instability in the development of childhood acute lymphoblastic leukaemia
NG2 antigen is a therapeutic target for MLL-rearranged B-cell acute lymphoblastic leukemia
Whole genome sequencing provides comprehensive genetic testing in childhood B-cell acute lymphoblastic leukaemia
VEGF - a novel therapeutic target in central nervous system acute lymphoblastic leukaemia
Uncommon manifestations of acute lymphoblastic leukaemia (ALL)
The age of the bone marrow microenvironment influences B-cell acute lymphoblastic leukaemia progression via CXCR5-CXCL13
Emerging molecular subtypes and therapeutic targets in B-cell precursor acute lymphoblastic leukemia
Characterisation of FLT3 alterations in childhood acute lymphoblastic leukaemia
Correction to: Pegaspargase: A Review in Acute Lymphoblastic Leukaemia
Molecular processes involved in B cell acute lymphoblastic leukaemia
TARGET based m6A methylation-related genes predict prognosis relapsed B-cell acute lymphoblastic leukemia
Temporal changes of the incidence of childhood B-cell precursor acute lymphoblastic leukaemia in Germany during the COVID-19 pandemic